In the latest quarter, 4 analysts provided ratings for BioLine Rx (NASDAQ:BLRX), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings ...

CLACTON-ON-SEA, ENGLAND / ACCESSWIRE / March 16, 2021 / Bioline Agrosciences, well known for innovation in product and technology, is launching CART® (Climate Adapted Release Technology) to further ...

ALVINSTON, ON, Oct. 26, 2023 /PRNewswire/ -- BioLiNE® Gold, an innovative fulvic based product from BioLiNE® Corp. has been approved for CE certification as a biostimulant under the new EU regulations ...

As global fertiliser markets face mounting volatility, the partnership introduces microbial nutrition technologies designed to reduce input costs, improve nutrient-use efficiency, and strengthen farm ...

CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the JetSeq™ DNA Library ...

The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures. It delivers the easy handling of ePTFE with the reduced suture hole ...

The PCR reagents portfolio includes all components required for PCR and real-time PCR: DNA polymerases and master mixes, reverse transcriptases, nucleotides, buffers and additives. Bioline’s PCR and ...

Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results ...

ALVINSTON, ON, CANADA, October 29, 2024 /EINPresswire.com/ -- BioLiNE ® Gold, an innovative biostimulant product from BioLiNE ® Corp., attains certification ...

Bioline’s 2010 revenues are expected to exceed $12 million. Meridian Bioscience confirmed the completion of a $23.3 million cash acquisition of molecular biology reagents firm Bioline. Headquartered ...